Implementation of an effective program for quality assurance and quality control in living cell therapy: a 2-year experience with autolymphocyte therapy.
du Moulin
G C
GC
Department of Quality Assurance and Quality Control, Cellcor, Inc., Newton, Massachusetts 02159.
Liu
V
V
Osband
M E
ME
D001781:Blood Component Removal / Q000379:methods; D016913:Blood Component Transfusion / Q000379:methods*; D001804:Blood Transfusion, Autologous / Q000379:methods*; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy; D002469:Cell Separation / Q000379:methods; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy; D007958:Leukocyte Count; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology / Q000637:transplantation*; D009362:Neoplasm Metastasis; D011785:Quality Assurance, Health Care; D011786:Quality Control; D014481:United States; D014486:United States Food and Drug Administration